Leaderboard
Popular Content
Showing content with the highest reputation on 01/25/21 in all areas
-
4 points
-
4 points
-
I’m not telling DND how to do their jobs but, shouldn’t they be focusing on enforcing our rights in the Philippine Sea? It’s their mandate to protect the country from outside threats and inside threats. But this is just weird. Fighting UP students and teachers? On Social media? Like an old person? Saving the students from being recruited? The University develops great minds into greater minds, not mediocre minds into less mediocre. If a student got recruited by the rebels... by all means deal with them your way. Those easily manipulated students were destined to be printed as casualties in the newspapers anyways. Anong klaseng matalino ang galing sa hirap at pupunta pa din sa bundok para maghirap? Sinisira lang ng mga yan ang reputation ng UP. Ako galing sa mahirap, papunta sa parlor para magpaganda... to manipulate men, so that they may burn bright! Please click the heart —>3 points
-
3 points
-
Meanwhile, on the other side of the planet... breakfast is served! My favorite sunny side up egg!3 points
-
Major cities in Japan are in lockdown. No ramen this weekend. Another supermarket bento meal 😀3 points
-
Late working lunch... I always work through lunch and sometimes dinner... Chicken adobo today3 points
-
3 points
-
3 points
-
3 points
-
Spicy Jin ramen. I can't finish it. I noticed, I'm eating less and less everyday.3 points
-
i dont think i will eat this all! Sa totoo lng cravings lang pero after maluto wala nako gana😓 Time check 1:40am craving satisfied.. bakedsushi,veggie dumpling samyang spicy cheese flavor2 points
-
Di hamak na mas takot akong maging DDS yung anak ko kesa maging aktibista. Kadiri kaya mga dds parang di tinubuan ng utak.2 points
-
2 points
-
I wonder why the admissions are questionable? Didn't they pass the UPCAT? What makes middle class or low income more deserving of a spot in UP? Everybody is treated equally. Their minds evaluated regardless of social status and financial standing. So if someone rich passed the UPCAT, then he/she deserves to be an isko/iska. If someone from the middle class or low income sector passed UPCAT, then they are also deserving. No bias. No prejudice. Just a community of young minds. I came from a middle class family and mingled with those from the rich ones. Our professors graded us based on performance and not by how much our families are worth. Also, yes the Filipino people paid for our tuition.. not the government as they seem to always forget. And like other universities, the youths are enriching their minds not only academically but socially and politically. The youth, not just those from UP, are voicing out injustices. They fight for freedom. Freedom from oppression. Freedom from corruption. They ask for good governance. Again, not just UP youth. Lastly, out of hundreds of thousands of students, how many ended up an NPA? This isn't about protecting the youth. This is now about silencing critics.2 points
-
2 points
-
Half a bowl of lomi... Since I started my diet a week ago, I noticed that my capacity to eat is becoming less and less..2 points
-
2 points
-
2 points
-
2 points
-
2 points
-
What's on your Netflix like list? What are you binge watching this weekend? Series that you've finished on Netflix? Series/Movie you want to recommend. Drop them all in this thread.1 point
-
Experiencing vertigo now due to coding for 10 hours straight. My body wants to rest but my mind is still very active.1 point
-
1 point
-
1 point
-
1 point
-
Feeling ya know today, i think im gonna have my period.💦1 point
-
What's the betting some of us from other countries have already been vaccinated according to the schedules of their respective host countries?1 point
-
1 point
-
1 point
-
1 point
-
IN SINGAPORE - 60,000 have received first dose of Covid-19 vaccine Singapore's Covid-19 vaccine programme will kick into high gear in the coming weeks, with more than 60,000 people having received their first doses of the jab, said Health Minister Gan Kim Yong. While delays are expected for vaccine shipments due to supply issues, the Government is monitoring the situation closely to ensure there are enough jabs for all Singaporeans and long-term residents by the third quarter of this year. Healthcare assistants from Ren Ci @ Bukit Batok Street 52 Nursing Home receiving the Pfizer-BioNTech Covid-19 vaccine on Jan 11. The Health Ministry said there will be some delays in shipments of the Pfizer-BioNTech vaccine because of upgrading works at Pfizer's manufacturing plant in Belgium. ST PHOTO: GAVIN FOO Mr Gan, co-chair of the multi-ministerial task force tackling the pandemic, said at a media briefing yesterday that about 10,000 individuals received their vaccine doses on Wednesday, and more will be doing so soon. "These numbers are expected to rise substantially in the coming weeks, as we continue to ramp up our vaccination capacity and operations while maintaining the highest standards of safety," he added. In a statement, the Ministry of Health (MOH) said 39 staff at the National Centre for Infectious Diseases have already received their second dose of the vaccine. This means that they have completed the full vaccination regimen, and will have built up maximum protection in two weeks' time. The Pfizer-BioNTech vaccine - the only one approved here to date - requires two injections, given 21 days apart. MOH said there will be some delays in the shipments of the Pfizer-BioNTech vaccine because of upgrading works at Pfizer's manufacturing plant in Belgium. Mr Gan said one particular shipment has been delayed, but is still scheduled to arrive in time for the vaccination programme. But he added that disruptions from time to time should be expected, due to uncertainties that remain surrounding the global vaccine roll-out. He pointed out that manufacturers might divert some of their supplies to other areas that may need vaccines more urgently due to huge outbreaks. Vaccine production and logistics arrangements could also be interrupted, he noted. Singaporeans should thus not wait to get vaccinated and do so as soon as they are given the chance. "When your turn comes for the vaccination, please do make an appointment early, because there will always be a possibility of a disruption as we go along, as we move forward," he said. MAJORITY OF SIDE EFFECTS VERY MILD Many of these symptoms in fact reflect the body's immune system responding to the vaccine dose that has been injected in them, and there will be some that may have more serious side effects which include allergic reactions of a variety of different grades of severity. ASSOCIATE PROFESSOR KENNETH MAK, MINISTRY OF HEALTH'S DIRECTOR OF MEDICAL SERVICES. HE NOTED THAT, IN GENERAL, THE MAJORITY OF SIDE EFFECTS HAVE BEEN VERY MILD AND THEY INCLUDE PAIN, REDNESS, SWELLING, SORENESS OF THE MUSCLES, AS WELL AS FATIGUE AND FEVER. Singapore is expecting more Covid-19 vaccine deliveries in the next few months, including from American biotechnology firm Moderna and China's Sinovac. Asked for an update on the review of these vaccines, MOH's director of medical services Kenneth Mak said a decision is expected soon on one of the vaccines under evaluation, which he did not name. "The other vaccine, I understand we are still clarifying further details with the company that produces the vaccine," he added. "We are hopeful that if we are able to get all the information necessary for evaluation, then HSA (Health Sciences Authority) can complete its review process and then give approval for the other vaccines as well." Asked about the side effects experienced by those who have been vaccinated here, Prof Mak said the Government has received some reports of "adverse effects" as they arise. It is currently compiling reports on these and submitting them to its vaccine expert panel for review and recommendations. In general, the majority of side effects reported in various countries that have launched vaccination programmes have been very mild, he said. These include pain, redness, swelling, soreness of the muscles, as well as fatigue and fever. "Many of these symptoms in fact reflect the body's immune system responding to the vaccine dose that has been injected in them, and there will be some that may have more serious side effects which include allergic reactions of a variety of different grades of severity." The authorities are still compiling and organising the data, and will give an update when ready, Prof Mak added. On vaccine passports - proof of vaccination usually for travel purposes - Education Minister Lawrence Wong said Singapore is still studying the matter. For example, the Government will consider reducing the quarantine requirement if it is proven that those inoculated are immune and cannot transmit Covid-19 to others. This would apply to foreign visitors and returning Singaporeans who have received their jabs. "But these are still early days. We are still studying the data and the evidence very carefully before we make any decisions on this matter," Mr Wong said. Original content from this website https://www.straitstimes.com/singapore/60000-have-received-first-dose-of-covid-19-vaccine1 point
-
1 point
-
1 point
-
1 point
-
1 point
-
1 point
-
1 point
-
1 point
-
1 point
-
scrambled egg with leeks and Japanese mayo Sunnyside up egg with pepper and oregano hardboiled egg with salt and Japanese mayo1 point
-
Bro, the estimated cost is indicated above. Schedule is still up in the clouds. Maybe people in congress have inside info.1 point
-
1 point
-
Interesting topic. I'm not officially part of the govt but I'm a tambay of congress (my name says it all) I can't confirm or deny any info... My boss instructed me to come to Batasan for _______, no other details were given.1 point
-
1 point
-
He he he ... If I'm not mistaken, no vaccines have been authorized for use in the Philippines as of this writing. Sat. 02 Jan. If anyone answers "yes" now, he / she may be investigated by the government in reference to unauthorized use of vaccines.1 point
-
Novavax, a late-stage US biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. This Maryland company is smaller compared to other vaccine manufacturers. They received a $1.6 billion grant from the US government’s Operation Warp Speed to produce 100 million doses by 2021. How their vaccines work: According to an article published in the Science Magazine, a peer-reviewed academic journal of the American Association for the Advancement of Science, Novavax first inserts baculovirus into moth cells. The baculovirus, a pathogen that attacks insects, will make moth cells produce a protein called spike – which is present in coronavirus. The spikes are then harvested by scientists and mixed with a “synthetic soap like particle” where the spikes can latch on. A compound called saponin, also derived from plants and trees, is also added to boost the immune response. The NVX‑CoV2373 vaccine aims to produce anti spike antibodies that can block SARS-CoV-2 infection. Status development: As of November 30, Novavax said in a statement that it has completed the enrollment of its 15,000-patient UK Phase 3 trial. The company added that has fully enrolled the Phase 2b trial in South Africa. “Novavax expects its pivotal Phase 3 clinical trial in the United States and Mexico to begin in the coming weeks. More than 100 trial sites have been selected with some alternate sites in place, should they be needed,” the company added. Roll-out: Since the vaccine is still in its early trial stages, there is still no expected release date.1 point
-
AstraZeneca is a British-Swedish multinational pharmaceutical and biopharmaceutical company that focuses on the development and commercialization of prescription medicine. Their medicines are targeted for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection, and neuroscience diseases. AstraZeneca collaborated with the University of Oxford to create a COVID-19 vaccine. How their vaccine works: Like Russia’s Sputnik V, AstraZeneca’s vaccines use a genetically altered virus called adenovirus. This virus, which is not harmful to recipients, will carry spike protein (like the “crowns” in coronavirus). Injecting this, in theory, will help the immune system to recognize and attack coronavirus. AstraZeneca’s vaccine requires a regular fridge temperature for storage. Status development: AstraZeneca and the University of Oxford announced on December 8 that it finished the Phase 3 interim analysis for the vaccine. The researchers noted that the efficacy rate for two doses – with the first dose at half strength – reached 90 percent. While a combination of two full-strength doses only resulted in 62 percent efficacy. Issues and concerns: Scientists questioned the vaccine efficacy rate after the reported error in dosage. In a report published by the New York Times on November 25, experts inquired how the combination of half dosage for the first shot and full dosage for the second shot resulted in a 90 percent efficacy rate.1 point
-
The Gamelaya Research Institute of Epidemiology and Microbiology is a Russian medical-research institute founded in 1891. According to Gamelaya, it “runs one of the unique “virus libraries” in the world and has its own vaccine production facility.” Aside from their research for the COVID-19 vaccine, they are also working to develop a vaccine against Ebola and the Middle East Respiratory Syndrome (MERS). How their vaccine works: Sputnik V is a two-part adenovirus-based vector vaccine. It uses a vector (an engineered virus that lacks the gene to reproduce) to send a message in cells to produce spike proteins. “The gene from adenovirus, which causes the infection, is removed while a gene with the code of a protein from another virus spike is inserted,” the institute explained. “This inserted element is safe for the body but still helps the immune system to react and produce antibodies, which protect us from the infection,” it added. Sputnik V is stored in a regular refrigerator temperature (in dry form). Status development: Gamaleya on November 24 announced that it has finished the second interim analysis of clinical trial data for Sputnik V. “The Sputnik V vaccine’s efficacy is confirmed at 91.4% based on data analysis of the final control point of clinical trials. The Sputnik V vaccine efficacy against severe cases of coronavirus is 100%,” Gamaleya reported. In October, the Russian Direct Investment Fund (RDIF) submitted applications to the World Health Organization for an Emergency Use Listing and prequalification of Sputnik V. According to a report on Monday, Russia is almost done completing its clinical trials for its COVID-19 vaccine for domestic animals and mink. Issues and concerns: Some scientists have recently expressed concerns towards Sputnik V due to a “lack of safety data.” However, Russia denounced the criticisms.1 point
-
US-based multinational pharmaceutical corporation, Pfizer, is also known as one of the world’s largest pharmaceutical companies. On the other hand, BioNTech SE is a German biotechnology company that focuses on individualized immunotherapies. How their vaccine works: Pfizer-BioNTech’s vaccine is similar to Moderna’s mRNA-1273 in the sense that it uses mRNA to eliminate the new coronavirus SARS-CoV-2. Pfizer-BioNTech’s vaccine requires storage with a temperature of -70 degrees Celsius. Status development: Pfizer and BioNTech concluded the Phase 3 study for their vaccine on November 18. Meanwhile, the USFDA on December 12 granted an emergency use authorization for the vaccine, and on December 14 started its use in New York City. The United Kingdom, the first country in the world to conduct mass inoculation against COVID-19 starting December 8, likewise used the vaccine developed by Pfizer and BioNTech. On Monday, Singapore Prime Minister Lee Hsien Long announced the approval of the Pfizer-BioNTech vaccine for his country’s mass vaccination program that will likely begin by end-December. Later, Jordan announced it had approved emergency use of the Pfizer-BioNTech coronavirus vaccine. Pfizer’s vaccine showed a 95 percent efficacy rate during its study. Issues and concerns: U.K.’s Medicines and Healthcare Products Regulatory Agency (MHRA) on December 10 issued an anaphylaxis warning on the Pfizer-BioNTech vaccine after reports of three cases of adverse reactions. According to MHRA, there were two reports of anaphylaxis and one possible allergic reaction after administering the vaccines. “Any person with a history of anaphylaxis to a vaccine, medicine or food should not receive the Pfizer BioNTech vaccine,” MHRA Chief Executive June Raine said in a statement. “Most people will not get anaphylaxis and the benefits in protecting people against COVID-19 outweigh the risks… You can be completely confident that this vaccine has met the MHRA’s robust standards of safety, quality and effectiveness,” Raine assured. Roll-out: Pfizer-BioNTech began its first shipment of the vaccines to several states in America on December 13.1 point
